PDS Biotechnology Corp — Director's Dealing 2020

Jul 6, 2020

SEC Form 3 — Initial Statement of Beneficial Ownership

Issuer: PDS Biotechnology Corp (PDSB)
CIK: 0001472091
Period of Report: 2020-06-23

Reporting Person: King Michael N. (N/A)

Holdings (Derivative)

Security	Exercise Price	Expiration	Underlying	Shares	Ownership
Employee Stock Option (Right to Buy)	$6.87	2024-12-15	Common Stock (52934)		Direct
Employee Stock Option (Right to Buy)	$9.04	2029-03-14	Common Stock (44871)		Direct

Footnotes

F1: On December 15, 2014, the date of grant, the option was subject to the following vesting schedule: 16,227 options vested on the date of grant and on each monthly anniversary of the date of grant, 1/24 of the options vested. On March 15, 2019, in connection with the merger between the Issuer and private PDS Biotechnology Corporation, the option was accelerated and the shares underlying the option became fully vested and immediately exercisable.

F2: The option was fully vested and immediately exercisable on the date of grant.